Related Experiment Video

Updated: Jun 23, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[How to manage lipid profiles and their interpretation in patients with coronary heart disease?]

Michel Farnier1

  • 1Endocrinologie maladies métaboliques, Point Médical, F-21000, Dijon, France. michelfarnier@nerim.net

Presse Medicale (Paris, France : 1983)
|April 21, 2009
PubMed

Insights

Accurate plasma lipid measurement within 24 hours of acute coronary syndrome onset is crucial. Follow-up testing 1-3 months later helps manage cardiovascular risk factors like LDL cholesterol and triglycerides.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Chemistry
  • Lipidology

Context:

  • Acute coronary syndrome (ACS) necessitates timely lipid assessment.
  • Lipid profiles guide treatment initiation and goal evaluation post-ACS.
  • Standard lipid markers and emerging atherogenic particle measures are discussed.

Purpose:

  • To outline optimal timing and interpretation of plasma lipid measurements after ACS.
  • To highlight the role of various lipid markers in cardiovascular risk assessment.
  • To provide guidance on lipid management in patients with coronary artery disease.

Summary:

  • Plasma lipids should be measured within 24 hours of ACS symptom onset and again 1-3 months later.
  • Low-density lipoprotein (LDL) cholesterol remains a primary marker, but non-high-density lipoprotein (HDL)-cholesterol and apolipoprotein B offer better cardiovascular risk insights.
  • Non-HDL-cholesterol is a secondary target for patients with high triglycerides, and managing triglycerides and HDL-cholesterol is vital for preventing recurrence in statin-treated coronary patients.

Impact:

  • Establishes evidence-based recommendations for lipid monitoring in ACS.
  • Promotes the use of more comprehensive lipid markers for improved cardiovascular risk stratification.
  • Aims to reduce recurrent cardiovascular events through optimized lipid management strategies.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...